David Earnshaw To Move To MSD
This article was originally published in Scrip
Executive Summary
David Earnshaw is to become head of Public Policy Europe & Canada at MSD, based in Brussels. Earnshaw, who will take up his new position on Feb. 15, 2016, is presently president and senior adviser in Burson-Marsteller's Brussels office, where he has held a number of leadership positions advising a range of private and public sector clients in areas such as pharmaceuticals, food, automotive and technology. MSD is a tradename of Merck & Co., Inc.
You may also be interested in...
EU Countries Offered Funding To Contribute to African Regulatory Strengthening
Training projects are intended to strengthen the African regulatory environment, boost the capacity of the African Medicines Agency, facilitate regulatory reliance, and increase joint new drug assessments.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.